These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 23370795)

  • 1. Parallel buprenorphine phMRI responses in conscious rodents and healthy human subjects.
    Becerra L; Upadhyay J; Chang PC; Bishop J; Anderson J; Baumgartner R; Schwarz AJ; Coimbra A; Wallin D; Nutile L; George E; Maier G; Sunkaraneni S; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Borsook D
    J Pharmacol Exp Ther; 2013 Apr; 345(1):41-51. PubMed ID: 23370795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Investigation of cross-species translatability of pharmacological MRI in awake nonhuman primate - a buprenorphine challenge study.
    Seah S; Asad AB; Baumgartner R; Feng D; Williams DS; Manigbas E; Beaver JD; Reese T; Henry B; Evelhoch JL; Chin CL
    PLoS One; 2014; 9(10):e110432. PubMed ID: 25337714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of CNS pain circuitry by intravenous and sublingual doses of buprenorphine.
    Upadhyay J; Anderson J; Baumgartner R; Coimbra A; Schwarz AJ; Pendse G; Wallin D; Nutile L; Bishop J; George E; Elman I; Sunkaraneni S; Maier G; Iyengar S; Evelhoch JL; Bleakman D; Hargreaves R; Becerra L; Borsook D
    Neuroimage; 2012 Feb; 59(4):3762-73. PubMed ID: 22119647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Test-retest reliability of the BOLD pharmacological MRI response to ketamine in healthy volunteers.
    De Simoni S; Schwarz AJ; O'Daly OG; Marquand AF; Brittain C; Gonzales C; Stephenson S; Williams SC; Mehta MA
    Neuroimage; 2013 Jan; 64():75-90. PubMed ID: 23009959
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug-anaesthetic interaction in phMRI: the case of the psychotomimetic agent phencyclidine.
    Gozzi A; Schwarz A; Crestan V; Bifone A
    Magn Reson Imaging; 2008 Sep; 26(7):999-1006. PubMed ID: 18486387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhanced buprenorphine analgesia with the addition of ultra-low-dose naloxone in healthy subjects.
    La Vincente SF; White JM; Somogyi AA; Bochner F; Chapleo CB
    Clin Pharmacol Ther; 2008 Jan; 83(1):144-52. PubMed ID: 17568402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Buprenorphine: new pharmacological aspects.
    Cowan A
    Int J Clin Pract Suppl; 2003 Feb; (133):3-8; discussion 23-4. PubMed ID: 12665117
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different profiles of buprenorphine-induced analgesia and antihyperalgesia in a human pain model.
    Koppert W; Ihmsen H; Körber N; Wehrfritz A; Sittl R; Schmelz M; Schüttler J
    Pain; 2005 Nov; 118(1-2):15-22. PubMed ID: 16154698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Xanomeline modulation of the blood oxygenation level-dependent signal in awake rats: development of pharmacological magnetic resonance imaging as a translatable pharmacodynamic biomarker for central activity and dose selection.
    Baker S; Chin CL; Basso AM; Fox GB; Marek GJ; Day M
    J Pharmacol Exp Ther; 2012 Apr; 341(1):263-73. PubMed ID: 22267203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tramadol induces conditioned place preference in rats: interactions with morphine and buprenorphine.
    Zhang M; Jing L; Liu Q; Wen RT; Li JX; Li YL; Gong Q; Liang JH
    Neurosci Lett; 2012 Jun; 520(1):87-91. PubMed ID: 22626615
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversibility of opioid receptor occupancy of buprenorphine in vivo.
    Englberger W; Kögel B; Friderichs E; Strassburger W; Germann T
    Eur J Pharmacol; 2006 Mar; 534(1-3):95-102. PubMed ID: 16490191
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Partial versus full agonists for opioid-mediated analgesia--focus on fentanyl and buprenorphine.
    Zuurmond WW; Meert TF; Noorduin H
    Acta Anaesthesiol Belg; 2002; 53(3):193-201. PubMed ID: 12461829
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Robust, unbiased general linear model estimation of phMRI signal amplitude in the presence of variation in the temporal response profile.
    Pendse GV; Schwarz AJ; Baumgartner R; Coimbra A; Upadhyay J; Borsook D; Becerra L
    J Magn Reson Imaging; 2010 Jun; 31(6):1445-57. PubMed ID: 20512898
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential sensitivity of three experimental pain models in detecting the analgesic effects of transdermal fentanyl and buprenorphine.
    Koltzenburg M; Pokorny R; Gasser UE; Richarz U
    Pain; 2006 Dec; 126(1-3):165-74. PubMed ID: 16901645
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potency differences for D-Phe-Cys-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 as an antagonist of peptide and alkaloid micro-agonists in an antinociception assay.
    Sterious SN; Walker EA
    J Pharmacol Exp Ther; 2003 Jan; 304(1):301-9. PubMed ID: 12490605
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping brain activity following administration of a nicotinic acetylcholine receptor agonist, ABT-594, using functional magnetic resonance imaging in awake rats.
    Skoubis PD; Hradil V; Chin CL; Luo Y; Fox GB; McGaraughty S
    Neuroscience; 2006; 137(2):583-91. PubMed ID: 16289887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine blocks epsilon- and micro-opioid receptor-mediated antinociception in the mouse.
    Mizoguchi H; Spaulding A; Leitermann R; Wu HE; Nagase H; Tseng LF
    J Pharmacol Exp Ther; 2003 Jul; 306(1):394-400. PubMed ID: 12721333
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction of mu-opioid receptor agonists and antagonists with the analgesic effect of buprenorphine in mice.
    Kögel B; Christoph T; Strassburger W; Friderichs E
    Eur J Pain; 2005 Oct; 9(5):599-611. PubMed ID: 16139189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regional effects of methadone maintenance compared to heroin dependence on mu-opioid receptor desensitization in rat brain.
    Martin TJ; Kahn WR; Xiao R; Childers SR
    Synapse; 2007 Mar; 61(3):176-84. PubMed ID: 17152089
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predictors of outcome in LAAM, buprenorphine, and methadone treatment for opioid dependence.
    Marsch LA; Stephens MA; Mudric T; Strain EC; Bigelow GE; Johnson RE
    Exp Clin Psychopharmacol; 2005 Nov; 13(4):293-302. PubMed ID: 16366759
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.